HQ Function

Formerly served as the primary center for research and development, clinical operations, and corporate administration.

Notable Features:

The facility likely included advanced laboratory spaces for exosome research, process development, and analytics, alongside modern office environments.

Work Culture:

Prior to its closure, the work culture was likely dynamic and science-driven, characteristic of a clinical-stage biotech, with a strong emphasis on innovation, collaboration, and advancing cutting-edge therapies.

HQ Significance:

The Cambridge headquarters was crucial for Codiak's efforts to advance its engEx® Platform and develop its pipeline of exosome therapeutics, benefiting from the rich biotech ecosystem of the Boston area.

Values Reflected in HQ: The headquarters would have aimed to reflect Codiak's commitment to scientific excellence, innovation in drug delivery, and the pursuit of transformative medicines.

Location:

As a clinical-stage company, Codiak BioSciences' global presence was mainly characterized by its clinical trial activities, which may have involved sites and investigators in multiple countries. It did not maintain a significant physical office presence globally beyond its US headquarters. Its collaborations and partnerships might have extended internationally.

Street Address:

35 Cambridgepark Drive, Suite 500

City:

Cambridge

State/Province:

MA

Country:

USA